Insider Monkey

CVS Gets Higher Target as Bernstein Cites Management Confidence

CVS Health Corporation (NYSE:CVS) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 12, Bernstein raised the firm’s price target on CVS Health Corporation (NYSE:CVS) to ...

CVS Health Corporation (CVS) board approves quarterly dividend as Cantor Fitzgerald and Bernstein assert bullishness

CVS Health Corporation (NYSE:CVS) is one of the best blue-chip stocks to buy for 2026. On January 6, CVS Health Corporation ...

Bernstein Reaffirms Their Hold Rating on CVS Health (CVS)

In a report released yesterday, Lance Wilkes from Bernstein maintained a Hold rating on CVS Health, with a price target of $91.00. The company’s shares closed yesterday at $82.68.
Insider Monkey

CVS Health Corporation (CVS) Sees Higher Price Target Despite PBM Pressures

CVS Health Corporation (NYSE:CVS) is among the cheap healthcare stocks to buy heading into 2026. On December 4, Bernstein SocGen Group lifted the price target on CVS Health Corporation (NYSE:CVS) to ...